CG Oncology, Inc.

NasdaqGS:CGON Stock Report

Market Cap: US$2.0b

CG Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CGON Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Dec 24SellUS$19,600,000Hong Fang SongIndividual700,000US$28.00
29 Aug 24SellUS$8,000,023Hong Fang SongIndividual226,245US$35.36
29 Aug 24SellUS$15,000,066Unique Diamond Investments LimitedCompany424,210US$35.36
29 Jan 24BuyUS$38,000Corleen RocheIndividual2,000US$19.00
29 Jan 24BuyUS$24,985Vijay KasturiIndividual1,315US$19.00
29 Jan 24BuyUS$4,999,983Hong Fang SongIndividual263,157US$19.00
29 Jan 24BuyUS$15,200,000Decheng Capital LLCCompany800,000US$19.00

Insider Trading Volume

Insider Buying: CGON insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CGON?
Owner TypeNumber of SharesOwnership Percentage
Private Companies586,9820.868%
General Public3,210,3844.75%
Public Companies3,543,5335.24%
Individual Insiders3,789,7615.6%
VC/PE Firms12,891,28619.1%
Institutions43,607,72964.5%

Dilution of Shares: CGON only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 76.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.51%
The Vanguard Group, Inc.
5,081,352US$147.9m126%no data
6.89%
Longitude Capital Management Co., LLC
4,662,268US$135.7m0%26.67%
6.74%
Decheng Capital LLC
4,558,812US$132.7m-16.8%32.24%
5.43%
TCG Crossover Management, LLC
3,670,206US$106.8m0%9.38%
5.35%
Hong Fang Song
3,617,859US$105.3m-16.2%no data
5.28%
BlackRock, Inc.
3,570,927US$103.9m80.7%no data
5.24%
Kissei Pharmaceutical Co., Ltd.
3,543,533US$103.2m0%no data
4.69%
Braidwell LP
3,170,875US$92.3m-4.19%4.03%
2.62%
Kynam Capital Management, LP
1,770,805US$51.5m3,180%4.02%
2.51%
State Street Global Advisors, Inc.
1,700,653US$49.5m73%no data
2.45%
Avidity Partners Management, L.P.
1,656,000US$48.2m27.8%2.68%
2.26%
Janus Henderson Group plc
1,526,534US$44.4m6.97%0.02%
2.07%
RA Capital Management, L.P.
1,397,433US$40.7m0%0.49%
1.99%
RTW Investments, LP
1,344,074US$39.1m0%0.55%
1.81%
Franklin Resources, Inc.
1,223,893US$35.6m8.3%0.01%
1.66%
AllianceBernstein L.P.
1,124,905US$32.7m11.4%0.01%
1.59%
Geode Capital Management, LLC
1,078,527US$31.4m96.2%no data
1.47%
BVF Partners L.P.
994,596US$29.0m-58.9%0.89%
1.44%
Cormorant Asset Management, LP
975,000US$28.4m0%1.5%
1.43%
Polar Capital Holdings Plc
967,055US$28.2m0%0.1%
1.36%
Ally Bridge Group
922,248US$26.8m-65.4%10.73%
1.26%
Deerfield Management Company, L.P. Series C
850,695US$24.8m96.2%0.43%
1.14%
Frazier Life Sciences Management, LP
770,000US$22.4m0%0.83%
1.1%
Point72 Asset Management, L.P.
746,063US$21.7m568%0.05%
1.08%
Perceptive Advisors LLC
733,695US$21.4m0%0.48%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 00:59
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CG Oncology, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charlie YangBofA Global Research
Joshua SchimmerCantor Fitzgerald & Co.
Corinne JohnsonGoldman Sachs